Related Experiment Videos
Mechanisms and therapeutic implications of angiogenesis
1Institute of Molecular Medicine, University of Oxford, UK.
Abstract:
Angiogenesis is a key step in tumor growth and metastasis. Many angiogenic factors have been described, including vascular endothelial growth factor, basic fibroblast growth factor, and thymidine phosphorylase. More recently, a number of naturally occurring inhibitors of angiogenesis, including thrombospondin and angiostatin, have also been identified. The control of angiogenesis by inhibitors regulated by suppressor oncogenes or produced by tumors has emerged as an important mechanism. The development of quantitative assessment of vascular density in primary human tumors has produced a new independent marker of prognosis and could be helpful in selecting patients for antiangiogenic therapy. A large number of antiangiogenic agents are in development, however, new ways to assess their antitumor effects will be necessary for the treatment of advanced cancer. Stabilization of disease may occur by inhibiting new vessel growth, and thus, evidence for a decrease in blood supply should be sought by positron emission tomography scanning, magnetic resonance imaging, or other methods. Markers of angiogenesis in urine or blood will prove to be helpful in the monitoring of treatments.
Insights
Angiogenesis, the process of new blood vessel formation, is crucial for tumor growth. Inhibitors and new assessment methods are vital for developing effective anti-angiogenic therapies for advanced cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Angiogenesis is essential for tumor growth and metastasis.
- Key angiogenic factors and naturally occurring inhibitors have been identified.
- Tumor angiogenesis can be regulated by suppressor oncogenes and tumor-produced inhibitors.
Purpose of the Study:
- To highlight the importance of angiogenesis in cancer progression.
- To discuss the role of angiogenesis inhibitors in cancer therapy.
- To emphasize the need for new methods to assess anti-angiogenic treatment efficacy.
Main Methods:
- Review of current literature on angiogenesis factors and inhibitors.
- Discussion of quantitative assessment of vascular density as a prognostic marker.
- Exploration of imaging techniques (PET, MRI) for monitoring anti-angiogenic effects.
- Mention of potential blood and urine markers for treatment monitoring.
Main Results:
- Quantitative assessment of vascular density serves as an independent prognostic marker.
- Anti-angiogenic agents are under development for advanced cancer treatment.
- New methods are required to evaluate the antitumor effects of these agents.
Conclusions:
- Controlling angiogenesis is a critical strategy in cancer treatment.
- Vascular density assessment can aid in patient selection for anti-angiogenic therapy.
- Advanced imaging and biomarker monitoring are necessary for effective treatment evaluation.